← Eichor
Study identifier: NCT05906056 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Continuous Passive Motion Versus Heterotopic Ossification

Condition: Traumatic Brain Injury · Spinal Cord Injuries · Stroke  ·  Sponsor: University of Ioannina

PhaseNA
Planned participants20
Who can joinAll sexes, 15 Years to 70 Years
Healthy volunteersNo

About this study

The investigators hypothesize that Heterotopic Ossification (HO) formation can be suppressed if the application of a Continuous Passive Motion (CPM) device can be performed for a substantial amount of time. The investigators will use the following study design: a pilot study with 10 ICU patients receiving CPM and 10 matched cases which will follow a conventional physiotherapy program at the time of the conduction of the study. The comparison between the treatment and referent groups of the outcomes will prove the prophylactic power of CPM against HO.

This description comes directly from the study's public registry record.

Talk to the study team

Avraam Ploumis, MD, PhD  ·  + 30 693 2080701  ·  aploumis@uoi.gr

George I Vasileiadis, MD, PhD  ·  + 30 694 5789239  ·  givasileiadis@gmail.com

Always discuss trial participation with your own doctor first.

Locations (1)

Department of Physical and Rehabilitation MedicineIoannina, Epirus, GreeceRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05906056